Cargando…

Prevalence and Mortality-Related Factors of Multiple Myeloma in Taiwan

In this retrospective cohort study based in Taiwan, we reported the current epidemiology of patients with multiple myeloma and analyzed the factors affecting mortality. We identified 7285 patients with newly diagnosed multiple myeloma (MM) between 1997 and 2013 in Taiwan. Privileges data from the Na...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Jia-Hong, Chung, Chi-Hsiang, Wang, Yung-Chih, Hsu, Shun-Neng, Huang, Wen-Yen, Chien, Wu-Chien
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5132205/
https://www.ncbi.nlm.nih.gov/pubmed/27907052
http://dx.doi.org/10.1371/journal.pone.0167227
_version_ 1782471025532862464
author Chen, Jia-Hong
Chung, Chi-Hsiang
Wang, Yung-Chih
Hsu, Shun-Neng
Huang, Wen-Yen
Chien, Wu-Chien
author_facet Chen, Jia-Hong
Chung, Chi-Hsiang
Wang, Yung-Chih
Hsu, Shun-Neng
Huang, Wen-Yen
Chien, Wu-Chien
author_sort Chen, Jia-Hong
collection PubMed
description In this retrospective cohort study based in Taiwan, we reported the current epidemiology of patients with multiple myeloma and analyzed the factors affecting mortality. We identified 7285 patients with newly diagnosed multiple myeloma (MM) between 1997 and 2013 in Taiwan. Privileges data from the National Health Institute Research Database was used, as it is made readily available to the public in electronic format for research purposes. From 1997 to 2013, the average incidence of MM per 100,000 people was 1.83. The mortality accounted for an average of 0.44 per 100,000 deaths. In all 7285 inpatients with MM, the proportion of male patients was greater than that of female (59.90% vs. 40.10%); the mean age was 68.71 years with the proportion of those >55 years of age was 85.11%; and the proportion of a catastrophic illness was 66.51%. The death risk of the inpatient dialysis group was 3.044 times that of patients without dialysis (P <0.001). Moreover, the risk of death to men in the hospital setting was 1.162 times that of women (P = 0.012), and in the group of patients aged >55 years, the risk of in-hospital death was 1.511 times more than that in those aged ≤55 years (P <0.001). The risk of hospital death due to catastrophic illness was 1.347 times that of a non-catastrophic illness (P <0.001). Male patients and those >55 years of age had the most common prevalence of MM in Taiwan. Hemodialysis treatment, male sex, old age, and catastrophic illness were independent predictors of hospital mortality in patients with MM.
format Online
Article
Text
id pubmed-5132205
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-51322052016-12-21 Prevalence and Mortality-Related Factors of Multiple Myeloma in Taiwan Chen, Jia-Hong Chung, Chi-Hsiang Wang, Yung-Chih Hsu, Shun-Neng Huang, Wen-Yen Chien, Wu-Chien PLoS One Research Article In this retrospective cohort study based in Taiwan, we reported the current epidemiology of patients with multiple myeloma and analyzed the factors affecting mortality. We identified 7285 patients with newly diagnosed multiple myeloma (MM) between 1997 and 2013 in Taiwan. Privileges data from the National Health Institute Research Database was used, as it is made readily available to the public in electronic format for research purposes. From 1997 to 2013, the average incidence of MM per 100,000 people was 1.83. The mortality accounted for an average of 0.44 per 100,000 deaths. In all 7285 inpatients with MM, the proportion of male patients was greater than that of female (59.90% vs. 40.10%); the mean age was 68.71 years with the proportion of those >55 years of age was 85.11%; and the proportion of a catastrophic illness was 66.51%. The death risk of the inpatient dialysis group was 3.044 times that of patients without dialysis (P <0.001). Moreover, the risk of death to men in the hospital setting was 1.162 times that of women (P = 0.012), and in the group of patients aged >55 years, the risk of in-hospital death was 1.511 times more than that in those aged ≤55 years (P <0.001). The risk of hospital death due to catastrophic illness was 1.347 times that of a non-catastrophic illness (P <0.001). Male patients and those >55 years of age had the most common prevalence of MM in Taiwan. Hemodialysis treatment, male sex, old age, and catastrophic illness were independent predictors of hospital mortality in patients with MM. Public Library of Science 2016-12-01 /pmc/articles/PMC5132205/ /pubmed/27907052 http://dx.doi.org/10.1371/journal.pone.0167227 Text en © 2016 Chen et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Chen, Jia-Hong
Chung, Chi-Hsiang
Wang, Yung-Chih
Hsu, Shun-Neng
Huang, Wen-Yen
Chien, Wu-Chien
Prevalence and Mortality-Related Factors of Multiple Myeloma in Taiwan
title Prevalence and Mortality-Related Factors of Multiple Myeloma in Taiwan
title_full Prevalence and Mortality-Related Factors of Multiple Myeloma in Taiwan
title_fullStr Prevalence and Mortality-Related Factors of Multiple Myeloma in Taiwan
title_full_unstemmed Prevalence and Mortality-Related Factors of Multiple Myeloma in Taiwan
title_short Prevalence and Mortality-Related Factors of Multiple Myeloma in Taiwan
title_sort prevalence and mortality-related factors of multiple myeloma in taiwan
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5132205/
https://www.ncbi.nlm.nih.gov/pubmed/27907052
http://dx.doi.org/10.1371/journal.pone.0167227
work_keys_str_mv AT chenjiahong prevalenceandmortalityrelatedfactorsofmultiplemyelomaintaiwan
AT chungchihsiang prevalenceandmortalityrelatedfactorsofmultiplemyelomaintaiwan
AT wangyungchih prevalenceandmortalityrelatedfactorsofmultiplemyelomaintaiwan
AT hsushunneng prevalenceandmortalityrelatedfactorsofmultiplemyelomaintaiwan
AT huangwenyen prevalenceandmortalityrelatedfactorsofmultiplemyelomaintaiwan
AT chienwuchien prevalenceandmortalityrelatedfactorsofmultiplemyelomaintaiwan